InMode Ltd. (INMD)

NASDAQ: INMD · IEX Real-Time Price · USD
24.14
+1.32 (5.78%)
At close: Jun 24, 2022 4:00 PM
24.68
+0.54 (2.24%)
After-hours: Jun 24, 2022 7:58 PM EDT
5.78%
Market Cap 2.01B
Revenue (ttm) 377.96M
Net Income (ttm) 169.30M
Shares Out 83.08M
EPS (ttm) 1.97
PE Ratio 12.27
Forward PE 10.63
Dividend n/a
Ex-Dividend Date n/a
Volume 1,234,568
Open 23.31
Previous Close 22.82
Day's Range 22.88 - 24.14
52-Week Range 20.60 - 99.27
Beta 2.12
Analysts Buy
Price Target 56.10 (+132.4%)
Earnings Date Jul 27, 2022

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also des... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Aug 8, 2019
Employees 362
Stock Exchange NASDAQ
Ticker Symbol INMD
Full Company Profile

Financial Performance

In 2021, InMode's revenue was $357.57 million, an increase of 73.49% compared to the previous year's $206.11 million. Earnings were $164.97 million, an increase of 119.87%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for INMD stock is "Buy." The 12-month stock price forecast is 56.1, which is an increase of 132.39% from the latest price.

Price Target
$56.1
(132.39% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Here's My Top Value Stock to Buy Right Now

Its shares are dirt cheap, but the business is growing fast.

InMode Receives Health Canada Certification of EmpowerRF Women's Wellness Technology

IRVINE, Calif. , June 15, 2022 /PRNewswire/ -- InMode Ltd.

This Growth Stock Could 10X in 10 Years

It'll need to keep eating into its competitors' market share all the while.

7 Deeply Oversold Stocks to Buy Before They Bounce

Stocks often over sell after panicking investors get rid of shares, which eventually leads to the stock bouncing back dramatically. The post 7 Deeply Oversold Stocks to Buy Before They Bounce appeared f...

Other symbols: AMATCOINETSYMRNATGT

InMode to Participate at the UBS Healthcare One-on-One Virtual Day

YOKNEAM, Israel , May 23, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and ...

1 Company Disrupting Plastic Surgery, Not Patients

InMode's sales and profits have boomed, but you wouldn't know it from the company's share price.

This Is Why InMode Stock Fell 32% in April

The financial results are solid but investors are still lowering their expectations.

InMode Reports First Quarter 2022 Financial Results:

Quarterly Revenue of $85.9M, GAAP Net Income of $31M Represent 31% and 16% Year-Over-Year Growth, Respectively YOKNEAM, Israel, May 2, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leadi...

3 Growth Stocks That Will Beat Cathie Wood's Ark Innovation ETF This Year

These three companies are growing rapidly. These growth stocks should easily perform better than Cathie Wood's ETFs this year.

Other symbols: STEMXPEV

InMode Expects First Quarter 2022 Revenue Between $85.0-$85.5M, Non-GAAP Earnings per Diluted Share Between $0.38-$0.39

Conference call to be held on Monday, May 2, 2022, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 11, 2022 /PRNewswire/ --  InMode Ltd.

3 Under-the-Radar Biotech Stocks That Will Zoom Higher

Finding stocks with significant upside before the rest of the market sees what's happening can be highly profitable.

Other symbols: AFMDOM

InMode to Participate Virtually in a Fireside Chat at the 21st Annual Needham Healthcare Conference

YOKNEAM, Israel, April 5, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate virtually in a f...

3 Unstoppable Growth Stocks to Buy in a Stock Market Sell-Off

2022 has been unpredictable thus far, but these companies are likely to shine in the long run.

Other symbols: CRWDTTD

InMode Announces Share Repurchase Program of Up to 1 Million Shares

YOKNEAM, Israel, March 10, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced that its Board of Directors has appro...

InMode to Participate in Investor Conferences in March

YOKNEAM, Israel, March 2, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in the following...

7 Hot Stocks to Buy for a Cold Market

Investors are scared of inflation and rising interest rates, but these hot stocks have done well for awhile and should continue to do so. The post 7 Hot Stocks to Buy for a Cold Market appeared first on...

Other symbols: CLFEVGOFCXLKNCYLNGMGM

InMode Reports Record Fourth Quarter and Full Year 2021 Financial Results:

YOKNEAM, Israel, Feb. 10, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for...

3 Top Healthcare Stocks to Buy for February

Whether you're looking for growth or big dividends, the healthcare sector's got deals galore.

Other symbols: ABBVJNJ

Buy This Unstoppable Growth Stock Instead of NFTs in 2022

It doesn't need to be part of a speculative bubble to grow in value.

Is It Too Late to Buy InMode Stock?

Not even a little bit.

InMode Expects Record Fourth Quarter & Full Year 2021 Financial Results, Q4 Revenue Between $109.5M-$110M

YOKNEAM, Israel, Jan. 12, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq:  INMD ), a leading global provider of innovative medical technologies, announced today that it expects to release its financial result...

Here's Why InMode Stock Was Up 197% Last Year

Business is booming for this medical device company.

InMode Is Bringing a Paradigm Shift to Cosmetic Procedures

Traditional cosmetic surgery is expensive, invasive, and can be quite risky. This highly profitable company changes all of that.

InMode to Present at the 24th Needham Virtual Growth Conference

YOKNEAM, Israel, Jan. 3, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chairman and Chief Executive O...

A 10-Bagger in 2 Years? What You Need to Know About This Medical Device Stock

We've never seen margins this consistently high.